4-Bromo-8-methoxy-6-methylquinoline, 98+%, 500mg

N-(5-((4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)((4-methyl-3-(5-(thiophen-2-yl)nicotinamido)benzoyl)oxy)carbamoyl)-2-methylphenyl)-5-(thiophen-2-yl)nicotinamide, 97%, 50mg

1-(Benzyloxy)-4-iodo-1H-pyrazole, 95.0%, 250mg

2-(chloromethyl)-6,7-dimethyl-1H-benzimidazole hydrochloride, 95.0%, 1g

3-(4-Fluorophenyl)isoxazole, 95.0%, 100mg

4-Chloro-7-iodoquinoline-3-carbonitrile, 95.0%, 100mg

3-(4-Nitrophenyl)propan-1-ol, 95%, 10g

[Bis(2-methoxyethyl)amino]sulphur trifluoride 50wt% solution in Toluene, 95.0%, 25g

2-Bromo-6-methylaniline, 97.0%, 25g

Cyclobutylmethanamine>98.0%(GC)(T)1g

(S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole, 95.0%, 5g

N-(2-Chloro-3-(dimethylamino)allylidene)-N-methylmethanaminium hexafluorophosphate(V), 95.0%, 1kg

(S)-5-((9H-Fluoren-9-yl)methoxy)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-oxopentanoic acid, 97%, 1g